[1]仇晓威.群体药动学方法调整患者万古霉素使用效果的分析[J].医学信息,2023,36(22):97-100.[doi:10.3969/j.issn.1006-1959.2023.22.021]
　QIU Xiao-wei.Analysis of the Effect of Population Pharmacokinetic Methodon Adjusting the use of Vancomycin in Patients[J].Journal of Medical Information,2023,36(22):97-100.[doi:10.3969/j.issn.1006-1959.2023.22.021]
点击复制

群体药动学方法调整患者万古霉素使用效果的分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年22期
页码:
97-100
栏目:
论著
出版日期:
2023-11-15

文章信息/Info

Title:
Analysis of the Effect of Population Pharmacokinetic Methodon Adjusting the use of Vancomycin in Patients
文章编号:
1006-1959（2023）22-0097-04
作者:
仇晓威
（上海市嘉定区中心医院药剂科，上海 201800）
Author(s):
QIU Xiao-wei
(Department of Pharmacy,Jiading District Central Hospital,Shanghai 201800,China)
关键词:
万古霉素; 群体药动学; 个体化给药
Keywords:
Vancomycin; Population pharmacokinetics; Individual administration
分类号:
R969
DOI:
10.3969/j.issn.1006-1959.2023.22.021
文献标志码:
A
摘要:
目的 对群体药动学的方法在优化万古霉素个体化给药方案中的应用进行分析。方法 收集2020年9月-2022年10月入住上海市嘉定区中心医院并接受万古霉素治疗的患者40例，根据万古霉素群体药动学（PPK）研究模型，采用群体药动学软件Java PK for desktop（JPKD），输入患者个体情况（体重、年龄、肌酐）、万古霉素初始方案和第1次万古霉素稳态血药谷浓度（Css，min）。利用贝叶斯反馈法方法估算药动学参数，根据给出的方案调整患者用药，计算调整方案的（Css，min）预测值，达稳态后测得调整方案的（Css，min）实测值，考察（Css，min）预测值与（Css，min）实测值的相关性。结果 纳入40例患者，（Css，min）初始值为（6.37±1.43）μg/ml，调整后（Css，min）实测值为（13.65±2.58）μg/ml，（Css，min）预测值为（13.11±1.16）μg/ml。调整后（Css，min）实测值与（Css，min）预测值比较，差异无统计学意义（P＞0.05）。调整后（Css，min）实测值与（Css，min）预测值有显著相关性（r=0.531，P＜0.05）。结论 群体药动学软件可以根据患者的个体情况调整万古霉素的给药方案，具有良好的血药浓度预测性。
Abstract:
Objective To analyze the application of population pharmacokinetics in optimizing the individualized dosage regimen of vancomycin.Methods A total of 40 patients who were admitted to Shanghai Jiading District Central Hospital from September 2020 to October 2022 and received vancomycin treatment were collected. According to the vancomycin population pharmacokinetic (PPK) research model, the population pharmacokinetic software Java PK for desktop (JPKD) was used to input the patient’s individual conditions (body weight, age, creatinine), vancomycin initial regimen and the first vancomycin steady-state blood trough concentration (Css,min). Bayesian feedback method was used to estimate the pharmacokinetic parameters, and the patient’s medication was adjusted according to the given regimen. The predicted value of (Css,min) of the adjustment regimen was calculated, and the measured value of (Css,min) of the adjustment regimen was measured after reaching steady state. The correlation between the predicted value of (Css,min) and the measured value of (Css,min) was investigated.Results The initial value of (Css,min) was (6.37±1.43)μg/ml, the measured value of (Css,min) after adjustment was (13.65±2.58)μg/ml, and the predicted value of (Css,min) was (13.11±1.16)μg/ml. There was no significant difference between the measured value of (Css,min) after adjustment and the predicted value of (Css,min) (P>0.05). There was a significant correlation between the measured value of adjusted (Css,min) and the predicted value of (Css,min) (r=0.531, P<0.05).Conclusion Population pharmacokinetic software can adjust the dosage regimen of vancomycin according to the individual situation of patients, and has good blood concentration prediction.

参考文献/References:

[1]Mühlberg E,Umst?覿tter F,Kleist C,et al.Renaissance of Vancomycin:Approaches for Breaking Antibiotic-Resistance in Multidrug-Resistant Bacteria[J].Canadian Journal of Microbiology,2019,66(8):11-16.[2]卢虹旭,李明,刘星,等.替考拉宁治疗儿童急性耐甲氧西林金黄色葡萄球菌性骨髓炎的疗效[J].中华医院感染学杂志,2020,30(17):2691-2695.[3]杨杰,李兰林.HPLC法测定人血浆中万古霉素的血药浓度[J].临床合理用药,2023,16(4):154-156,160.[4]张燕,胡琴,胡凯,等.高效液相色谱法测定血浆万古霉素药物浓度及其药物代谢动力学/药物效应动力学临床应用[J].老年医学研究,2023,4(2):25-30.[5]Lee BV,Fong G,Bolaris M,et al.Cost-benefit analysis comparing trough,two-level AUC and Bayesian AUC dosing for vancomycin[J].Clin Microbiol Infect,2021,27(9):1346.e1-1346.e7.[6]黄志莉,李兴德,宋沧桑,等.某三甲医院111例次万古霉素血药浓度监测结果与临床应用分析[J].中国药物滥用防治杂志,2023,29(3):431-436.[7]Zamoner W,Prado IRS,Balbi AL,et al.Vancomycin Dosing, Monitoring and Toxicity: Critical review of the clinical practice[J].Clinical and Experimental Pharmacology and Physiology,2019,46(4):1440-1681.[8]王翠红,叶蕊,吴小街,等.万古霉素治疗革兰阳性球菌血流感染患者的血药浓度监测[J].实用药物与临床,2017,20(6):644-647.[9]方洁,刘利艳,黄洁,等.优化万古霉素给药方案的研究[J].药学服务与研究,2017,17(3):179-182.[10]Aljutayli A,Marsot A,Nekka F.An Update on Population Pharmacokinetic Analyses of Vancomycin, Part I: In Adults[J].Clinical Pharmacokinetics,2020,59(1):671-698.[11]Turner RB,Kojiro K,Won R,et al.Prospective evaluation of vancomycin pharmacokinetics in a heterogeneous critically ill population[J].Diagnostic Microbiology and Infectious Disease,2018,92(4):346-351.[12]Diaz R,Afreixo V,Ramalheira E,et al.Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections-a systematic review and meta-analysis[J].Clin Microbiol Infect,2018,24(2):97-104.[13]屈昱晨,朱珠,韩俊萍,等.万古霉素群体药动学模型在特重度烧伤患者中的临床验证[J].中国感染控制杂志,2022,21(7):697-703.[14]郭仙忠,林荣芳,林玮玮.基于群体药动学模型的万古霉素个体化给药软件研制及应用[J].中国临床药理学与治疗学,2021,26(1):30-39.[15]刘晓玲,孙振国,胡冰.JPKD软件在颅脑术后肾功能亢进病人万古霉素应用中的指导价值[J].中国临床神经外科杂志,2022,27(12):974-976.[16]冯朴琼,何瑾,张峻,等.基于AUC_(0-24h)结合JPKD软件的万古霉素个体化药学服务实践[J].中国临床药学杂志,2022,31(9):709-711.[17]Drennan PG,Begg EJ,Gardiner SJ,et al．The dosing and monitoring of vancomycin: What is the best way forward?[J].Int J Antimicrob Agents,2019,53(4):401-407.[18]王宁,陈聪琴,黄洁,等.基于群体药代动力学软件优化重症感染患者万古霉素给药方案分析[J].中国药业,2020,29(16):47-50.[19]Sridharan K,Al Daylami A,Ajjawi Ｒ,et al．Clinical pharmacokineticsof vancomycin in critically ill children [J].Eur J Drug Metab Pharmacokinet,2019,44(6):807-816.[20]郑香宜,吴建华,吴东方.万古霉素血药浓度低于目标治疗浓度因素分析及给药方案优化[J].中国药师,2022,25(8):1442-1447.

相似文献/References:

[1]刘代华,罗宜辉.肾功能亢进及对药物代谢的影响[J].医学信息,2019,32(09):48.[doi:10.3969/j.issn.1006-1959.2019.09.016]
　LIU Dai-hua,LUO Yi-hui.Hyperkalemia and Effects on Drug Metabolism[J].Journal of Medical Information,2019,32(22):48.[doi:10.3969/j.issn.1006-1959.2019.09.016]
[2]张成汉.夫西地酸钠和万古霉素用于ICU病房耐甲氧西林 金黄色葡萄球菌患者的疗效比较[J].医学信息,2019,32(18):149.[doi:10.3969/j.issn.1006-1959.2019.18.051]
　ZHANG Cheng-han.Efficacy Comparison of Sodium Fusidate and Vancomycin to Treat Patients with Methicillin-resistant Staphylococcus Aureus in ICU Ward[J].Journal of Medical Information,2019,32(22):149.[doi:10.3969/j.issn.1006-1959.2019.18.051]
[3]林素梅,吕 聪,杨小叶,等.利奈唑胺治疗新生儿革兰阳性球菌败血症的疗效[J].医学信息,2020,33(05):142.[doi:10.3969/j.issn.1006-1959.2020.05.045]
　LIN Su-mei,Lyu Cong,YANG Xiao-ye,et al.Effect of Linezolid in the Treatment of Neonatal Gram-positive Cocci Sepsis[J].Journal of Medical Information,2020,33(22):142.[doi:10.3969/j.issn.1006-1959.2020.05.045]
[4]刘旭良,李伯庭,郑介柏,等.负压封闭引流技术联合外用万古霉素治疗骶尾部难愈性压疮的效果[J].医学信息,2022,35(17):37.[doi:10.3969/j.issn.1006-1959.2022.17.008]
　LIU Xu-liang,LI Bo-ting,ZHENG Jie-bo,et al.Effect of Vacuum Sealing Drainage Combined with Topical Vancomycin in the Treatment of Sacrococcygeal Refractory Pressure Sores[J].Journal of Medical Information,2022,35(22):37.[doi:10.3969/j.issn.1006-1959.2022.17.008]

更新日期/Last Update: 1900-01-01